Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record with results posted

Bispecific NK Engager AFM13 Combined With NK Cells for Patients With Recurrent of Refractory CD30 Positive Hodgkin or Non-Hodgkin Lymphomas

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04074746
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-10-01T00:03:37.761107+00:00
Published At
2026-09-30T00:00:00+00:00
Record Updated At
2026-09-30
Results Posted At
2026-09-30
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Recurrent Anaplastic Large Cell Lymphoma", "Recurrent B-Cell Non-Hodgkin Lymphoma", "Recurrent Classic Hodgkin Lymphoma", "Recurrent Mycosis Fungoides", "Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified", "Refractory Anaplastic Large Cell Lymphoma", "Refractory B-Cell Non-Hodgkin Lymphoma", "Refractory Classic Hodgkin Lymphoma", "Refractory Mycosis Fungoides", "Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-09-30"
protocolSection.identificationModule.nctId
"NCT04074746"
protocolSection.identificationModule.officialTitle
"Bispecific NK Engager AFM13 Combined With NK Cells for Patients With Recurrent of Refractory CD30 Positive Hodgkin or Non-Hodgkin Lymphomas"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2026-09-30"

Study condition terms

  • Recurrent Anaplastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent B-Cell Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Classic Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Mycosis Fungoides (protocolSection.conditionsModule.conditions)
  • Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified (protocolSection.conditionsModule.conditions)
  • Refractory Anaplastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Refractory B-Cell Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Refractory Classic Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Refractory Mycosis Fungoides (protocolSection.conditionsModule.conditions)
  • Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.